Issued Patents All Time
Showing 51–75 of 108 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9745580 | Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21 | Joseph Collard | 2017-08-29 |
| 9745584 | Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4 | Joseph Collard | 2017-08-29 |
| 9745582 | Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1 | Joseph Collard | 2017-08-29 |
| 9732339 | Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 | Joseph Collard | 2017-08-15 |
| 9725717 | Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3 | Joseph Collard | 2017-08-08 |
| 9725756 | Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIP | Joseph Collard, Carlos Coito | 2017-08-08 |
| 9714423 | Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1 | Joseph Collard | 2017-07-25 |
| 9708604 | Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1 | Joseph Collard, Carlos Coito | 2017-07-18 |
| 9677074 | Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3) | Joseph Collard | 2017-06-13 |
| 9663785 | Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1 | Joseph Collard | 2017-05-30 |
| 9624493 | Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1 | Joseph Collard | 2017-04-18 |
| 9611477 | Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP | Joseph Collard | 2017-04-04 |
| 9593330 | Treatment of frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN | Joseph Collard | 2017-03-14 |
| 9533004 | Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family | Joseph Collard | 2017-01-03 |
| 9528110 | Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP | Joseph Collard, Carlos Coito | 2016-12-27 |
| 9512427 | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene | Joseph Collard | 2016-12-06 |
| 9464287 | Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2 | Joseph Collard, Carlos Coito | 2016-10-11 |
| 9410155 | Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF | Joseph Collard | 2016-08-09 |
| 9394542 | Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG | Joseph Collard, Carlos Coito | 2016-07-19 |
| 9382538 | Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3 | Joseph Collard | 2016-07-05 |
| 9382543 | Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1 | Joseph Collard | 2016-07-05 |
| 9290766 | Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ) | Joseph Collard | 2016-03-22 |
| 9267136 | Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene | Joseph Collard | 2016-02-23 |
| 9234199 | Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS) | Joseph Collard | 2016-01-12 |
| 9222088 | Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA | Joseph Collard, Carlos Coito, Gang Shen | 2015-12-29 |